福瑞股份收盘上涨2.84%，滚动市盈率115.88倍，总市值114.96亿元

Company Overview - Furuya Co., Ltd. closed at 43.16 yuan, up 2.84%, with a rolling PE ratio of 115.88, marking a new low in 182 days, and a total market value of 11.496 billion yuan [1] - The company operates primarily in the liver disease sector, focusing on drug production and sales, diagnostic equipment R&D and sales, and related medical services [1] Financial Performance - For Q1 2025, the company reported revenue of 330 million yuan, a year-on-year increase of 2.35%, while net profit was 28.637 million yuan, reflecting a year-on-year decrease of 32.97%, with a gross margin of 76.76% [1] Shareholder Information - As of July 10, 2025, the number of shareholders for Furuya Co., Ltd. was 20,833, a decrease of 220 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 55.41, with a median of 37.94, placing Furuya Co., Ltd. at 107th in the industry ranking [2] - The company's static PE ratio is 101.48, and its price-to-book ratio is 6.45 [2]